aluates Reports

$ 0.0

Automative

Global Pneumococcal Vaccine Market Insights, Forecast to 2030

Published Date: July 2024

Report Code: QYRE-Auto-37E406

Global Pneumococcal Vaccine Market Insights and Forecast to 2028

BUY CHAPTERS

Global Pneumococcal Vaccine Market Insights, Forecast to 2030

Code: QYRE-Auto-37E406

Report

July 2024

Pages:95

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Pneumococcal Vaccine Market Size

The global Pneumococcal Vaccine market is projected to grow from US$ 7286.1 million in 2024 to US$ 7780.4 million by 2030, at a Compound Annual Growth Rate (CAGR) of 1.1% during the forecast period.

Pneumococcal Vaccine Market

Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria.

There are two types of Pneumococcal Vaccine: conjugate vaccines and polysaccharide vaccines.

23-Valent Pneumococcal Polysaccharide Vaccine (PPSV 23) is polysaccharide vaccine. Pneumococcal conjugate vaccines contain PCV 7/13 (Pfizer) and PCV10 (GSK).

At present, only MSD, Sanofipasteur and CDIBP can produce PPSV 23, and they hold key technologies and patents, with high-end customers, have been formed in the monopoly position in the industry. As for PCV 13, only Pfizer can supply it. And GSK is the only one manufacturing PCV 10. However, there are some companies working on research of Pneumococcal Vaccine. Pfizer is the leader of this industry with 84% market shares.

North America is the largest consumption market of Pneumococcal Vaccine with sales market share nearly 40%. The second place is Europe, following North America with sales market share over 18%. Asia-Pacific is another important market of Pneumococcal Vaccine, enjoy nearly 16% sales market share, but the consumption experienced a sharp decrease due to approval of government departments in last few years.

Report Covers:

This report presents an overview of global market for Pneumococcal Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Pneumococcal Vaccine, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Pneumococcal Vaccine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pneumococcal Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Pneumococcal Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by End User, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Pneumococcal Vaccine sales, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Pneumococcal Vaccine Market Report

Report Metric	Details
Report Name	Pneumococcal Vaccine Market
Accounted market size in 2024	US$ 7286.1 million
Forecasted market size in 2030	US$ 7780.4 million
CAGR	1.1
Base Year	2024
Forecasted years	2024 - 2030
Segment by Type	PPSV 23 PCV 7/13 PCV 10
Segment by End User	Child Adult
Segment by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	MSD, Sanofipasteur, CDIBP
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by End User, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Pneumococcal Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Pneumococcal Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by End User, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by End User and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by End User and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by End User, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by End User and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by End User and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pneumococcal Vaccine sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

FAQ for this report

How fast is Pneumococcal Vaccine Market growing?

Ans: The Pneumococcal Vaccine Market witnessing a CAGR of 1.1 during the forecast period 2024-2030.

What is the Pneumococcal Vaccine Market size in 2030?

Ans: The Pneumococcal Vaccine Market size in 2030 will be US$ 7780.4 million.

What is the Pneumococcal Vaccine Market share by region?

Ans: The second place is Europe, following North America with sales market share over 18%.

Who are the main players in the Pneumococcal Vaccine Market report?

Ans: The main players in the Pneumococcal Vaccine Market are MSD, Sanofipasteur, CDIBP

What are the Type segmentation covered in the Pneumococcal Vaccine Market report?

Ans: The Types covered in the Pneumococcal Vaccine Market report are PPSV 23, PCV 7/13, PCV 10

What are the End User segmentation covered in the Pneumococcal Vaccine Market report?

Ans: The End users covered in the Pneumococcal Vaccine Market report are Child, Adult

1 Study Coverage

1.1 Pneumococcal Vaccine Product Introduction

1.2 Market by Type

1.2.1 Global Pneumococcal Vaccine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 PPSV 23

1.2.3 PCV 7/13

1.2.4 PCV 10

1.3 Market by End User

1.3.1 Global Pneumococcal Vaccine Market Size Growth Rate by End User, 2019 VS 2023 VS 2030

1.3.2 Child

1.3.3 Adult

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Pneumococcal Vaccine Sales Estimates and Forecasts 2019-2030

2.2 Global Pneumococcal Vaccine Revenue by Region

2.2.1 Global Pneumococcal Vaccine Revenue by Region: 2019 VS 2023 VS 2030

2.2.2 Global Pneumococcal Vaccine Revenue by Region (2019-2024)

2.2.3 Global Pneumococcal Vaccine Revenue by Region (2025-2030)

2.2.4 Global Pneumococcal Vaccine Revenue Market Share by Region (2019-2030)

2.3 Global Pneumococcal Vaccine Sales Estimates and Forecasts 2019-2030

2.4 Global Pneumococcal Vaccine Sales by Region

2.4.1 Global Pneumococcal Vaccine Sales by Region: 2019 VS 2023 VS 2030

2.4.2 Global Pneumococcal Vaccine Sales by Region (2019-2024)

2.4.3 Global Pneumococcal Vaccine Sales by Region (2025-2030)

2.4.4 Global Pneumococcal Vaccine Sales Market Share by Region (2019-2030)

2.5 US & Canada

2.6 Europe

2.7 China

2.8 Asia (excluding China)

2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

3.1 Global Pneumococcal Vaccine Sales by Manufacturers

3.1.1 Global Pneumococcal Vaccine Sales by Manufacturers (2019-2024)

3.1.2 Global Pneumococcal Vaccine Sales Market Share by Manufacturers (2019-2024)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pneumococcal Vaccine in 2023

3.2 Global Pneumococcal Vaccine Revenue by Manufacturers

3.2.1 Global Pneumococcal Vaccine Revenue by Manufacturers (2019-2024)

3.2.2 Global Pneumococcal Vaccine Revenue Market Share by Manufacturers (2019-2024)

3.2.3 Global Top 10 and Top 5 Companies by Pneumococcal Vaccine Revenue in 2023

3.3 Global Key Players of Pneumococcal Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

3.4 Global Pneumococcal Vaccine Sales Price by Manufacturers

3.5 Analysis of Competitive Landscape

3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.5.2 Global Pneumococcal Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.6 Global Key Manufacturers of Pneumococcal Vaccine, Manufacturing Base Distribution and Headquarters

3.7 Global Key Manufacturers of Pneumococcal Vaccine, Product Offered and Application

3.8 Global Key Manufacturers of Pneumococcal Vaccine, Date of Enter into This Industry

3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Pneumococcal Vaccine Sales by Type

4.1.1 Global Pneumococcal Vaccine Historical Sales by Type (2019-2024)

4.1.2 Global Pneumococcal Vaccine Forecasted Sales by Type (2025-2030)

4.1.3 Global Pneumococcal Vaccine Sales Market Share by Type (2019-2030)

4.2 Global Pneumococcal Vaccine Revenue by Type

4.2.1 Global Pneumococcal Vaccine Historical Revenue by Type (2019-2024)

4.2.2 Global Pneumococcal Vaccine Forecasted Revenue by Type (2025-2030)

4.2.3 Global Pneumococcal Vaccine Revenue Market Share by Type (2019-2030)

4.3 Global Pneumococcal Vaccine Price by Type

4.3.1 Global Pneumococcal Vaccine Price by Type (2019-2024)

4.3.2 Global Pneumococcal Vaccine Price Forecast by Type (2025-2030)

5 Market Size by End User

5.1 Global Pneumococcal Vaccine Sales by End User

5.1.1 Global Pneumococcal Vaccine Historical Sales by End User (2019-2024)

5.1.2 Global Pneumococcal Vaccine Forecasted Sales by End User (2025-2030)

5.1.3 Global Pneumococcal Vaccine Sales Market Share by End User (2019-2030)

5.2 Global Pneumococcal Vaccine Revenue by End User

5.2.1 Global Pneumococcal Vaccine Historical Revenue by End User (2019-2024)

5.2.2 Global Pneumococcal Vaccine Forecasted Revenue by End User (2025-2030)

5.2.3 Global Pneumococcal Vaccine Revenue Market Share by End User (2019-2030)

5.3 Global Pneumococcal Vaccine Price by End User

5.3.1 Global Pneumococcal Vaccine Price by End User (2019-2024)

5.3.2 Global Pneumococcal Vaccine Price Forecast by End User (2025-2030)

6 US & Canada

6.1 US & Canada Pneumococcal Vaccine Market Size by Type

6.1.1 US & Canada Pneumococcal Vaccine Sales by Type (2019-2030)

6.1.2 US & Canada Pneumococcal Vaccine Revenue by Type (2019-2030)

6.2 US & Canada Pneumococcal Vaccine Market Size by End User

6.2.1 US & Canada Pneumococcal Vaccine Sales by End User (2019-2030)

6.2.2 US & Canada Pneumococcal Vaccine Revenue by End User (2019-2030)

6.3 US & Canada Pneumococcal Vaccine Market Size by Country

6.3.1 US & Canada Pneumococcal Vaccine Revenue by Country: 2019 VS 2023 VS 2030

6.3.2 US & Canada Pneumococcal Vaccine Sales by Country (2019-2030)

6.3.3 US & Canada Pneumococcal Vaccine Revenue by Country (2019-2030)

6.3.4 US

6.3.5 Canada

7 Europe

7.1 Europe Pneumococcal Vaccine Market Size by Type

7.1.1 Europe Pneumococcal Vaccine Sales by Type (2019-2030)

7.1.2 Europe Pneumococcal Vaccine Revenue by Type (2019-2030)

7.2 Europe Pneumococcal Vaccine Market Size by End User

7.2.1 Europe Pneumococcal Vaccine Sales by End User (2019-2030)

7.2.2 Europe Pneumococcal Vaccine Revenue by End User (2019-2030)

7.3 Europe Pneumococcal Vaccine Market Size by Country

7.3.1 Europe Pneumococcal Vaccine Revenue by Country: 2019 VS 2023 VS 2030

7.3.2 Europe Pneumococcal Vaccine Sales by Country (2019-2030)

7.3.3 Europe Pneumococcal Vaccine Revenue by Country (2019-2030)

7.3.4 Germany

7.3.5 France

7.3.6 U.K.

7.3.7 Italy

7.3.8 Russia

8 China

8.1 China Pneumococcal Vaccine Market Size

8.1.1 China Pneumococcal Vaccine Sales (2019-2030)

8.1.2 China Pneumococcal Vaccine Revenue (2019-2030)

8.2 China Pneumococcal Vaccine Market Size by End User

8.2.1 China Pneumococcal Vaccine Sales by End User (2019-2030)

8.2.2 China Pneumococcal Vaccine Revenue by End User (2019-2030)

9 Asia (excluding China)

9.1 Asia Pneumococcal Vaccine Market Size by Type

9.1.1 Asia Pneumococcal Vaccine Sales by Type (2019-2030)

9.1.2 Asia Pneumococcal Vaccine Revenue by Type (2019-2030)

9.2 Asia Pneumococcal Vaccine Market Size by End User

9.2.1 Asia Pneumococcal Vaccine Sales by End User (2019-2030)

9.2.2 Asia Pneumococcal Vaccine Revenue by End User (2019-2030)

9.3 Asia Pneumococcal Vaccine Sales by Region

9.3.1 Asia Pneumococcal Vaccine Revenue by Region: 2019 VS 2023 VS 2030

9.3.2 Asia Pneumococcal Vaccine Revenue by Region (2019-2030)

9.3.3 Asia Pneumococcal Vaccine Sales by Region (2019-2030)

9.3.4 Japan

9.3.5 South Korea

9.3.6 China Taiwan

9.3.7 Southeast Asia

9.3.8 India

10 Middle East, Africa and Latin America

10.1 Middle East, Africa and Latin America Pneumococcal Vaccine Market Size by Type

10.1.1 Middle East, Africa and Latin America Pneumococcal Vaccine Sales by Type (2019-2030)

10.1.2 Middle East, Africa and Latin America Pneumococcal Vaccine Revenue by Type (2019-2030)

10.2 Middle East, Africa and Latin America Pneumococcal Vaccine Market Size by End User

10.2.1 Middle East, Africa and Latin America Pneumococcal Vaccine Sales by End User (2019-2030)

10.2.2 Middle East, Africa and Latin America Pneumococcal Vaccine Revenue by End User (2019-2030)

10.3 Middle East, Africa and Latin America Pneumococcal Vaccine Sales by Country

10.3.1 Middle East, Africa and Latin America Pneumococcal Vaccine Revenue by Country: 2019 VS 2023 VS 2030

10.3.2 Middle East, Africa and Latin America Pneumococcal Vaccine Revenue by Country (2019-2030)

10.3.3 Middle East, Africa and Latin America Pneumococcal Vaccine Sales by Country (2019-2030)

10.3.4 Brazil

10.3.5 Mexico

10.3.6 Turkey

10.3.7 Israel

10.3.8 GCC Countries

11 Company Profiles

11.1 Pfizer

11.1.1 Pfizer Company Information

11.1.2 Pfizer Overview

11.1.3 Pfizer Pneumococcal Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.1.4 Pfizer Pneumococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Pfizer Recent Developments

11.2 GSK

11.2.1 GSK Company Information

11.2.2 GSK Overview

11.2.3 GSK Pneumococcal Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.2.4 GSK Pneumococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 GSK Recent Developments

11.3 MSD

11.3.1 MSD Company Information

11.3.2 MSD Overview

11.3.3 MSD Pneumococcal Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.3.4 MSD Pneumococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 MSD Recent Developments

11.4 Sanofipasteur

11.4.1 Sanofipasteur Company Information

11.4.2 Sanofipasteur Overview

11.4.3 Sanofipasteur Pneumococcal Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.4.4 Sanofipasteur Pneumococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Sanofipasteur Recent Developments

11.5 CDIBP

11.5.1 CDIBP Company Information

11.5.2 CDIBP Overview

11.5.3 CDIBP Pneumococcal Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.5.4 CDIBP Pneumococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 CDIBP Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Pneumococcal Vaccine Industry Chain Analysis

12.2 Pneumococcal Vaccine Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Pneumococcal Vaccine Production Mode & Process

12.4 Pneumococcal Vaccine Sales and Marketing

12.4.1 Pneumococcal Vaccine Sales Channels

12.4.2 Pneumococcal Vaccine Distributors

12.5 Pneumococcal Vaccine Customers

13 Market Dynamics

13.1 Pneumococcal Vaccine Industry Trends

13.2 Pneumococcal Vaccine Market Drivers

13.3 Pneumococcal Vaccine Market Challenges

13.4 Pneumococcal Vaccine Market Restraints

14 Key Findings in The Global Pneumococcal Vaccine Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Pneumococcal Vaccine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of PPSV 23

Table 3. Major Manufacturers of PCV 7/13

Table 4. Major Manufacturers of PCV 10

Table 5. Global Pneumococcal Vaccine Market Size Growth Rate by End User, 2019 VS 2023 VS 2030 (US$ Million)

Table 6. Global Pneumococcal Vaccine Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 7. Global Pneumococcal Vaccine Revenue by Region (2019-2024) & (US$ Million)

Table 8. Global Pneumococcal Vaccine Revenue by Region (2025-2030) & (US$ Million)

Table 9. Global Pneumococcal Vaccine Revenue Market Share by Region (2019-2024)

Table 10. Global Pneumococcal Vaccine Revenue Market Share by Region (2025-2030)

Table 11. Global Pneumococcal Vaccine Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 12. Global Pneumococcal Vaccine Sales by Region (2019-2024) & (K Doses)

Table 13. Global Pneumococcal Vaccine Sales by Region (2025-2030) & (K Doses)

Table 14. Global Pneumococcal Vaccine Sales Market Share by Region (2019-2024)

Table 15. Global Pneumococcal Vaccine Sales Market Share by Region (2025-2030)

Table 16. Global Pneumococcal Vaccine Sales by Manufacturers (2019-2024) & (K Doses)

Table 17. Global Pneumococcal Vaccine Sales Share by Manufacturers (2019-2024)

Table 18. Global Pneumococcal Vaccine Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 19. Global Pneumococcal Vaccine Revenue Share by Manufacturers (2019-2024)

Table 20. Global Key Players of Pneumococcal Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

Table 21. Pneumococcal Vaccine Price by Manufacturers 2019-2024 (USD/Dose)

Table 22. Global Pneumococcal Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 23. Global Pneumococcal Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pneumococcal Vaccine as of 2023)

Table 24. Global Key Manufacturers of Pneumococcal Vaccine, Manufacturing Base Distribution and Headquarters

Table 25. Global Key Manufacturers of Pneumococcal Vaccine, Product Offered and Application

Table 26. Global Key Manufacturers of Pneumococcal Vaccine, Date of Enter into This Industry

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Pneumococcal Vaccine Sales by Type (2019-2024) & (K Doses)

Table 29. Global Pneumococcal Vaccine Sales by Type (2025-2030) & (K Doses)

Table 30. Global Pneumococcal Vaccine Sales Share by Type (2019-2024)

Table 31. Global Pneumococcal Vaccine Sales Share by Type (2025-2030)

Table 32. Global Pneumococcal Vaccine Revenue by Type (2019-2024) & (US$ Million)

Table 33. Global Pneumococcal Vaccine Revenue by Type (2025-2030) & (US$ Million)

Table 34. Global Pneumococcal Vaccine Revenue Share by Type (2019-2024)

Table 35. Global Pneumococcal Vaccine Revenue Share by Type (2025-2030)

Table 36. Pneumococcal Vaccine Price by Type (2019-2024) & (USD/Dose)

Table 37. Global Pneumococcal Vaccine Price Forecast by Type (2025-2030) & (USD/Dose)

Table 38. Global Pneumococcal Vaccine Sales by End User (2019-2024) & (K Doses)

Table 39. Global Pneumococcal Vaccine Sales by End User (2025-2030) & (K Doses)

Table 40. Global Pneumococcal Vaccine Sales Share by End User (2019-2024)

Table 41. Global Pneumococcal Vaccine Sales Share by End User (2025-2030)

Table 42. Global Pneumococcal Vaccine Revenue by End User (2019-2024) & (US$ Million)

Table 43. Global Pneumococcal Vaccine Revenue by End User (2025-2030) & (US$ Million)

Table 44. Global Pneumococcal Vaccine Revenue Share by End User (2019-2024)

Table 45. Global Pneumococcal Vaccine Revenue Share by End User (2025-2030)

Table 46. Pneumococcal Vaccine Price by End User (2019-2024) & (USD/Dose)

Table 47. Global Pneumococcal Vaccine Price Forecast by End User (2025-2030) & (USD/Dose)

Table 48. US & Canada Pneumococcal Vaccine Sales by Type (2019-2024) & (K Doses)

Table 49. US & Canada Pneumococcal Vaccine Sales by Type (2025-2030) & (K Doses)

Table 50. US & Canada Pneumococcal Vaccine Revenue by Type (2019-2024) & (US$ Million)

Table 51. US & Canada Pneumococcal Vaccine Revenue by Type (2025-2030) & (US$ Million)

Table 52. US & Canada Pneumococcal Vaccine Sales by End User (2019-2024) & (K Doses)

Table 53. US & Canada Pneumococcal Vaccine Sales by End User (2025-2030) & (K Doses)

Table 54. US & Canada Pneumococcal Vaccine Revenue by End User (2019-2024) & (US$ Million)

Table 55. US & Canada Pneumococcal Vaccine Revenue by End User (2025-2030) & (US$ Million)

Table 56. US & Canada Pneumococcal Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 57. US & Canada Pneumococcal Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 58. US & Canada Pneumococcal Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 59. US & Canada Pneumococcal Vaccine Sales by Country (2019-2024) & (K Doses)

Table 60. US & Canada Pneumococcal Vaccine Sales by Country (2025-2030) & (K Doses)

Table 61. Europe Pneumococcal Vaccine Sales by Type (2019-2024) & (K Doses)

Table 62. Europe Pneumococcal Vaccine Sales by Type (2025-2030) & (K Doses)

Table 63. Europe Pneumococcal Vaccine Revenue by Type (2019-2024) & (US$ Million)

Table 64. Europe Pneumococcal Vaccine Revenue by Type (2025-2030) & (US$ Million)

Table 65. Europe Pneumococcal Vaccine Sales by End User (2019-2024) & (K Doses)

Table 66. Europe Pneumococcal Vaccine Sales by End User (2025-2030) & (K Doses)

Table 67. Europe Pneumococcal Vaccine Revenue by End User (2019-2024) & (US$ Million)

Table 68. Europe Pneumococcal Vaccine Revenue by End User (2025-2030) & (US$ Million)

Table 69. Europe Pneumococcal Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 70. Europe Pneumococcal Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 71. Europe Pneumococcal Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 72. Europe Pneumococcal Vaccine Sales by Country (2019-2024) & (K Doses)

Table 73. Europe Pneumococcal Vaccine Sales by Country (2025-2030) & (K Doses)

Table 74. China Pneumococcal Vaccine Sales by Type (2019-2024) & (K Doses)

Table 75. China Pneumococcal Vaccine Sales by Type (2025-2030) & (K Doses)

Table 76. China Pneumococcal Vaccine Revenue by Type (2019-2024) & (US$ Million)

Table 77. China Pneumococcal Vaccine Revenue by Type (2025-2030) & (US$ Million)

Table 78. China Pneumococcal Vaccine Sales by End User (2019-2024) & (K Doses)

Table 79. China Pneumococcal Vaccine Sales by End User (2025-2030) & (K Doses)

Table 80. China Pneumococcal Vaccine Revenue by End User (2019-2024) & (US$ Million)

Table 81. China Pneumococcal Vaccine Revenue by End User (2025-2030) & (US$ Million)

Table 82. Asia Pneumococcal Vaccine Sales by Type (2019-2024) & (K Doses)

Table 83. Asia Pneumococcal Vaccine Sales by Type (2025-2030) & (K Doses)

Table 84. Asia Pneumococcal Vaccine Revenue by Type (2019-2024) & (US$ Million)

Table 85. Asia Pneumococcal Vaccine Revenue by Type (2025-2030) & (US$ Million)

Table 86. Asia Pneumococcal Vaccine Sales by End User (2019-2024) & (K Doses)

Table 87. Asia Pneumococcal Vaccine Sales by End User (2025-2030) & (K Doses)

Table 88. Asia Pneumococcal Vaccine Revenue by End User (2019-2024) & (US$ Million)

Table 89. Asia Pneumococcal Vaccine Revenue by End User (2025-2030) & (US$ Million)

Table 90. Asia Pneumococcal Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 91. Asia Pneumococcal Vaccine Revenue by Region (2019-2024) & (US$ Million)

Table 92. Asia Pneumococcal Vaccine Revenue by Region (2025-2030) & (US$ Million)

Table 93. Asia Pneumococcal Vaccine Sales by Region (2019-2024) & (K Doses)

Table 94. Asia Pneumococcal Vaccine Sales by Region (2025-2030) & (K Doses)

Table 95. Middle East, Africa and Latin America Pneumococcal Vaccine Sales by Type (2019-2024) & (K Doses)

Table 96. Middle East, Africa and Latin America Pneumococcal Vaccine Sales by Type (2025-2030) & (K Doses)

Table 97. Middle East, Africa and Latin America Pneumococcal Vaccine Revenue by Type (2019-2024) & (US$ Million)

Table 98. Middle East, Africa and Latin America Pneumococcal Vaccine Revenue by Type (2025-2030) & (US$ Million)

Table 99. Middle East, Africa and Latin America Pneumococcal Vaccine Sales by End User (2019-2024) & (K Doses)

Table 100. Middle East, Africa and Latin America Pneumococcal Vaccine Sales by End User (2025-2030) & (K Doses)

Table 101. Middle East, Africa and Latin America Pneumococcal Vaccine Revenue by End User (2019-2024) & (US$ Million)

Table 102. Middle East, Africa and Latin America Pneumococcal Vaccine Revenue by End User (2025-2030) & (US$ Million)

Table 103. Middle East, Africa and Latin America Pneumococcal Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 104. Middle East, Africa and Latin America Pneumococcal Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 105. Middle East, Africa and Latin America Pneumococcal Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 106. Middle East, Africa and Latin America Pneumococcal Vaccine Sales by Country (2019-2024) & (K Doses)

Table 107. Middle East, Africa and Latin America Pneumococcal Vaccine Sales by Country (2025-2030) & (K Doses)

Table 108. Pfizer Company Information

Table 109. Pfizer Description and Major Businesses

Table 110. Pfizer Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 111. Pfizer Pneumococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 112. Pfizer Recent Developments

Table 113. GSK Company Information

Table 114. GSK Description and Major Businesses

Table 115. GSK Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 116. GSK Pneumococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 117. GSK Recent Developments

Table 118. MSD Company Information

Table 119. MSD Description and Major Businesses

Table 120. MSD Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 121. MSD Pneumococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 122. MSD Recent Developments

Table 123. Sanofipasteur Company Information

Table 124. Sanofipasteur Description and Major Businesses

Table 125. Sanofipasteur Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 126. Sanofipasteur Pneumococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 127. Sanofipasteur Recent Developments

Table 128. CDIBP Company Information

Table 129. CDIBP Description and Major Businesses

Table 130. CDIBP Pneumococcal Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)

Table 131. CDIBP Pneumococcal Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 132. CDIBP Recent Developments

Table 133. Key Raw Materials Lists

Table 134. Raw Materials Key Suppliers Lists

Table 135. Pneumococcal Vaccine Distributors List

Table 136. Pneumococcal Vaccine Customers List

Table 137. Pneumococcal Vaccine Market Trends

Table 138. Pneumococcal Vaccine Market Drivers

Table 139. Pneumococcal Vaccine Market Challenges

Table 140. Pneumococcal Vaccine Market Restraints

Table 141. Research Programs/Design for This Report

Table 142. Key Data Information from Secondary Sources

Table 143. Key Data Information from Primary Sources

List of Figures

Figure 1. Pneumococcal Vaccine Product Picture

Figure 2. Global Pneumococcal Vaccine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Pneumococcal Vaccine Market Share by Type in 2023 & 2030

Figure 4. PPSV 23 Product Picture

Figure 5. PCV 7/13 Product Picture

Figure 6. PCV 10 Product Picture

Figure 7. Global Pneumococcal Vaccine Market Size Growth Rate by End User, 2019 VS 2023 VS 2030 (US$ Million)

Figure 8. Global Pneumococcal Vaccine Market Share by End User in 2023 & 2030

Figure 9. Child

Figure 10. Adult

Figure 11. Pneumococcal Vaccine Report Years Considered

Figure 12. Global Pneumococcal Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Pneumococcal Vaccine Revenue 2019-2030 (US$ Million)

Figure 14. Global Pneumococcal Vaccine Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 15. Global Pneumococcal Vaccine Revenue Market Share by Region (2019-2030)

Figure 16. Global Pneumococcal Vaccine Sales 2019-2030 ((K Doses)

Figure 17. Global Pneumococcal Vaccine Sales Market Share by Region (2019-2030)

Figure 18. US & Canada Pneumococcal Vaccine Sales YoY (2019-2030) & (K Doses)

Figure 19. US & Canada Pneumococcal Vaccine Revenue YoY (2019-2030) & (US$ Million)

Figure 20. Europe Pneumococcal Vaccine Sales YoY (2019-2030) & (K Doses)

Figure 21. Europe Pneumococcal Vaccine Revenue YoY (2019-2030) & (US$ Million)

Figure 22. China Pneumococcal Vaccine Sales YoY (2019-2030) & (K Doses)

Figure 23. China Pneumococcal Vaccine Revenue YoY (2019-2030) & (US$ Million)

Figure 24. Asia (excluding China) Pneumococcal Vaccine Sales YoY (2019-2030) & (K Doses)

Figure 25. Asia (excluding China) Pneumococcal Vaccine Revenue YoY (2019-2030) & (US$ Million)

Figure 26. Middle East, Africa and Latin America Pneumococcal Vaccine Sales YoY (2019-2030) & (K Doses)

Figure 27. Middle East, Africa and Latin America Pneumococcal Vaccine Revenue YoY (2019-2030) & (US$ Million)

Figure 28. The Pneumococcal Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 29. The Top 5 and 10 Largest Manufacturers of Pneumococcal Vaccine in the World: Market Share by Pneumococcal Vaccine Revenue in 2023

Figure 30. Global Pneumococcal Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 31. Global Pneumococcal Vaccine Sales Market Share by Type (2019-2030)

Figure 32. Global Pneumococcal Vaccine Revenue Market Share by Type (2019-2030)

Figure 33. Global Pneumococcal Vaccine Sales Market Share by End User (2019-2030)

Figure 34. Global Pneumococcal Vaccine Revenue Market Share by End User (2019-2030)

Figure 35. US & Canada Pneumococcal Vaccine Sales Market Share by Type (2019-2030)

Figure 36. US & Canada Pneumococcal Vaccine Revenue Market Share by Type (2019-2030)

Figure 37. US & Canada Pneumococcal Vaccine Sales Market Share by End User (2019-2030)

Figure 38. US & Canada Pneumococcal Vaccine Revenue Market Share by End User (2019-2030)

Figure 39. US & Canada Pneumococcal Vaccine Revenue Share by Country (2019-2030)

Figure 40. US & Canada Pneumococcal Vaccine Sales Share by Country (2019-2030)

Figure 41. U.S. Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)

Figure 42. Canada Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)

Figure 43. Europe Pneumococcal Vaccine Sales Market Share by Type (2019-2030)

Figure 44. Europe Pneumococcal Vaccine Revenue Market Share by Type (2019-2030)

Figure 45. Europe Pneumococcal Vaccine Sales Market Share by End User (2019-2030)

Figure 46. Europe Pneumococcal Vaccine Revenue Market Share by End User (2019-2030)

Figure 47. Europe Pneumococcal Vaccine Revenue Share by Country (2019-2030)

Figure 48. Europe Pneumococcal Vaccine Sales Share by Country (2019-2030)

Figure 49. Germany Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)

Figure 50. France Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)

Figure 51. U.K. Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)

Figure 52. Italy Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)

Figure 53. Russia Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)

Figure 54. China Pneumococcal Vaccine Sales Market Share by Type (2019-2030)

Figure 55. China Pneumococcal Vaccine Revenue Market Share by Type (2019-2030)

Figure 56. China Pneumococcal Vaccine Sales Market Share by End User (2019-2030)

Figure 57. China Pneumococcal Vaccine Revenue Market Share by End User (2019-2030)

Figure 58. Asia Pneumococcal Vaccine Sales Market Share by Type (2019-2030)

Figure 59. Asia Pneumococcal Vaccine Revenue Market Share by Type (2019-2030)

Figure 60. Asia Pneumococcal Vaccine Sales Market Share by End User (2019-2030)

Figure 61. Asia Pneumococcal Vaccine Revenue Market Share by End User (2019-2030)

Figure 62. Asia Pneumococcal Vaccine Revenue Share by Region (2019-2030)

Figure 63. Asia Pneumococcal Vaccine Sales Share by Region (2019-2030)

Figure 64. Japan Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)

Figure 65. South Korea Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)

Figure 66. China Taiwan Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)

Figure 67. Southeast Asia Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)

Figure 68. India Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)

Figure 69. Middle East, Africa and Latin America Pneumococcal Vaccine Sales Market Share by Type (2019-2030)

Figure 70. Middle East, Africa and Latin America Pneumococcal Vaccine Revenue Market Share by Type (2019-2030)

Figure 71. Middle East, Africa and Latin America Pneumococcal Vaccine Sales Market Share by End User (2019-2030)

Figure 72. Middle East, Africa and Latin America Pneumococcal Vaccine Revenue Market Share by End User (2019-2030)

Figure 73. Middle East, Africa and Latin America Pneumococcal Vaccine Revenue Share by Country (2019-2030)

Figure 74. Middle East, Africa and Latin America Pneumococcal Vaccine Sales Share by Country (2019-2030)

Figure 75. Brazil Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)

Figure 76. Mexico Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)

Figure 77. Turkey Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)

Figure 78. Israel Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)

Figure 79. GCC Countries Pneumococcal Vaccine Revenue (2019-2030) & (US$ Million)

Figure 80. Pneumococcal Vaccine Value Chain

Figure 81. Pneumococcal Vaccine Production Process

Figure 82. Channels of Distribution

Figure 83. Distributors Profiles

Figure 84. Bottom-up and Top-down Approaches for This Report

Figure 85. Data Triangulation

Figure 86. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions